Importer of Controlled Substances; Notice of Application, 8793 [E7-3297]

Download as PDF Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices DEPARTMENT OF JUSTICE Drug Drug Enforcement Administration Importer of Controlled Substances; Notice of Application Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to issuing a registration under this Section to a bulk manufacturer of a controlled substance in schedule I or II and prior to issuing a regulation under 21 U.S.C. 952(a) authorizing the importation of such a substance, provide manufacturers holding registrations for the bulk manufacture of the substance an opportunity for a hearing. Therefore, in accordance with 21 CFR 1301.34(a), this is notice that on January 9, 2007, Sigma Aldrich Manufacturing LLC., Subsidiary of Sigma-Aldrich Company, 3500 Dekalb Street, St. Louis, Missouri 63118, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule I and II: cprice-sewell on PROD1PC62 with NOTICES Drug Schedule Cathinone (1235) .......................... Methcathinone (1237) ................... Aminorex (1585) ........................... Gamma Hydroxybutyric Acid (2010) ........................................ Methaqualone (2565) ................... Ibogaine (7260) ............................ Lysergic acid diethylamide (7315) Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ...... Mescaline (7381) .......................... 4-Bromo-2,5dimethoxyamphetamine (7391) 4-Bromo-2,5dimethoxyphenethylamine (7392) ........................................ 4-Methyl-2,5dimethoxyamphetamine (7395) 2,5-Dimethoxyamphetamine (7396) ........................................ 3,4-Methylenedioxyamphetamine (7400) ........................................ N-Hydroxy-3,4methylenedioxyamphetamine (7402) ........................................ 3,4-Methylenedioxy-Nethylamphetamine (7404) ......... 3,4Methylenedioxymethamphetamine (MDMA) (7405) ................... 4-Methoxyamphetamine (7411) .... Bufotenine (7433) ......................... Diethyltryptamine (7434) .............. Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... Psilocyn (7438) ............................. N-Ethyl-1-phenylcyclohexylamine (7455) ........................................ N-Benzylpiperazine (BZP) (7493) Trifluoromethylphenyl Piperazine (7494) ........................................ Heroin (9200) ................................ VerDate Aug<31>2005 15:22 Feb 26, 2007 Jkt 211001 I I I I I I I I I I I I I I I I I I I I I I I I I I I I Schedule Normorphine (9313) ..................... Etonitazene (9624) ....................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Glutethimide (2550) ...................... Nabilone (7379) ............................ Phencyclidine (7471) .................... Cocaine (9041) ............................. Codeine (9050) ............................. Diprenorphine (9058) .................... Oxycodone (9143) ........................ Hydromorphone (9150) ................ Diphenoxylate (9170) ................... Ecgonine (9180) ........................... Ethylmorphine (9190) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ...................... Meperidine (9230) ........................ Methadone (9250) ........................ Dextropropoxyphene, bulk (nondosage forms) (9273) ............... Morphine (9300) ........................... Thebaine (9333) ........................... Opium powdered (9639) ............... Oxymorphone (9652) .................... Fentanyl (9801) ............................ I I II II II II II II II II II II II II II II II II II II II II II Frm 00116 Fmt 4703 Sfmt 4703 to be required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied. Dated: February 16, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–3297 Filed 2–26–07; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF LABOR Employment and Training Administration [TA–W–60,837] II II II II II II The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. Any bulk manufacturer who is presently, or is applying to be, registered with DEA to manufacture such basic classes of controlled substances may file comments or objections to the issuance of the proposed registration and may, at the same time, file a written request for a hearing on such application pursuant to 21 CFR 1301.43 and in such form as prescribed by 21 CFR 1316.47. Any such written comments or objections being sent via regular mail should be addressed, in quintuplicate, to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, Washington, D.C. 20537, Attention: DEA Federal Register Representative/ODL; or any being sent via express mail should be sent to DEA Headquarters, Attention: DEA Federal Register Representative/ ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be filed no later than March 29, 2007. This procedure is to be conducted simultaneously with and independent of the procedures described in 21 CFR 1301.34(b), (c), (d), (e) and (f). As noted in a previous notice published in the Federal Register on September 23, 1975, (40 FR 43745–46), all applicants for registration to import a basic classes of any controlled substances listed in schedule I or II are, and will continue PO 00000 8793 Bright Horizons/MSX/Norfolk Assembly Plant, a/k/a Ford Family Service & Learning Center, Norfolk, VA; Notice of Termination of Investigation Pursuant to Section 221 of the Trade Act of 1974, as amended, an investigation was initiated on January 26, 2007, in response to a worker petition filed on behalf of workers at Bright Horizons/MSX/Norfolk Assembly Plant, Norfolk, Virginia. The petitioners have requested that the petition be withdrawn. Consequently, the investigation has been terminated. Signed at Washington, DC, this 15th day of February, 2007. Richard Church, Certifying Officer, Division of Trade Adjustment Assistance. [FR Doc. E7–3277 Filed 2–26–07; 8:45 am] BILLING CODE 4510–FN–P DEPARTMENT OF LABOR Employment and Training Administration Notice of Determinations Regarding Eligibility To Apply for Worker Adjustment Assistance and Alternative Trade Adjustment Assistance In accordance with Section 223 of the Trade Act of 1974, as amended (19 U.S.C. 2273) the Department of Labor herein presents summaries of determinations regarding eligibility to apply for trade adjustment assistance for workers (TA–W) number and alternative trade adjustment assistance (ATAA) by (TA–W) number issued during the E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 72, Number 38 (Tuesday, February 27, 2007)]
[Notices]
[Page 8793]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-3297]



[[Page 8793]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this Section to a bulk manufacturer of a 
controlled substance in schedule I or II and prior to issuing a 
regulation under 21 U.S.C. 952(a) authorizing the importation of such a 
substance, provide manufacturers holding registrations for the bulk 
manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with 21 CFR 1301.34(a), this is notice 
that on January 9, 2007, Sigma Aldrich Manufacturing LLC., Subsidiary 
of Sigma-Aldrich Company, 3500 Dekalb Street, St. Louis, Missouri 
63118, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as an importer of the basic 
classes of controlled substances listed in schedule I and II:

------------------------------------------------------------------------
                             Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235).............................................          I
Methcathinone (1237).........................................          I
Aminorex (1585)..............................................          I
Gamma Hydroxybutyric Acid (2010).............................          I
Methaqualone (2565)..........................................          I
Ibogaine (7260)..............................................          I
Lysergic acid diethylamide (7315)............................          I
Marihuana (7360).............................................          I
Tetrahydrocannabinols (7370).................................          I
Mescaline (7381).............................................          I
4-Bromo-2,5-dimethoxyamphetamine (7391)......................          I
4-Bromo-2,5-dimethoxyphenethylamine (7392)...................          I
4-Methyl-2,5-dimethoxyamphetamine (7395).....................          I
2,5-Dimethoxyamphetamine (7396)..............................          I
3,4-Methylenedioxyamphetamine (7400).........................          I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)...............          I
3,4-Methylenedioxy-N-ethylamphetamine (7404).................          I
3,4-Methylenedioxymethamphetamine (MDMA) (7405)..............          I
4-Methoxyamphetamine (7411)..................................          I
Bufotenine (7433)............................................          I
Diethyltryptamine (7434).....................................          I
Dimethyltryptamine (7435)....................................          I
Psilocybin (7437)............................................          I
Psilocyn (7438)..............................................          I
N-Ethyl-1-phenylcyclohexylamine (7455).......................          I
N-Benzylpiperazine (BZP) (7493)..............................          I
Trifluoromethylphenyl Piperazine (7494)......................          I
Heroin (9200)................................................          I
Normorphine (9313)...........................................          I
Etonitazene (9624)...........................................          I
Amphetamine (1100)...........................................         II
Methamphetamine (1105).......................................         II
Methylphenidate (1724).......................................         II
Amobarbital (2125)...........................................         II
Pentobarbital (2270).........................................         II
Secobarbital (2315)..........................................         II
Glutethimide (2550)..........................................         II
Nabilone (7379)..............................................         II
Phencyclidine (7471).........................................         II
Cocaine (9041)...............................................         II
Codeine (9050)...............................................         II
Diprenorphine (9058).........................................         II
Oxycodone (9143).............................................         II
Hydromorphone (9150).........................................         II
Diphenoxylate (9170).........................................         II
Ecgonine (9180)..............................................         II
Ethylmorphine (9190).........................................         II
Hydrocodone (9193)...........................................         II
Levorphanol (9220)...........................................         II
Meperidine (9230)............................................         II
Methadone (9250).............................................         II
Dextropropoxyphene, bulk (non-dosage forms) (9273)...........         II
Morphine (9300)..............................................         II
Thebaine (9333)..............................................         II
Opium powdered (9639)........................................         II
Oxymorphone (9652)...........................................         II
Fentanyl (9801)..............................................         II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
sale to research facilities for drug testing and analysis.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Deputy Assistant 
Administrator, Office of Diversion Control, Drug Enforcement 
Administration, Washington, D.C. 20537, Attention: DEA Federal Register 
Representative/ODL; or any being sent via express mail should be sent 
to DEA Headquarters, Attention: DEA Federal Register Representative/
ODL, 2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must 
be filed no later than March 29, 2007.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e) and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import a basic classes of any controlled substances 
listed in schedule I or II are, and will continue to be required to 
demonstrate to the Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, that the requirements for 
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and 
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.

    Dated: February 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E7-3297 Filed 2-26-07; 8:45 am]
BILLING CODE 4410-09-P